Form 8-K - Current report:
SEC Accession No. 0001104659-25-026123
Filing Date
2025-03-20
Accepted
2025-03-20 16:05:56
Documents
13
Period of Report
2025-03-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm259771d1_8k.htm   iXBRL 8-K 25508
  Complete submission text file 0001104659-25-026123.txt   197478

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rsls-20250314.xsd EX-101.SCH 3048
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rsls-20250314_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rsls-20250314_pre.xml EX-101.PRE 22381
15 EXTRACTED XBRL INSTANCE DOCUMENT tm259771d1_8k_htm.xml XML 3572
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 949-429-6680
ReShape Lifesciences Inc. (Filer) CIK: 0001427570 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37897 | Film No.: 25756463
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)